| scholarly article | Q13442814 |
| P356 | DOI | 10.7326/0003-4819-127-6-199709150-00002 |
| P8608 | Fatcat ID | release_vya6bmgqxrgzvjcxeyaqulr7ii |
| P953 | full work available online at | http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.365.4072 |
| P698 | PubMed publication ID | 9312998 |
| P2093 | author name string | D. Douer | |
| T. L. Fong | |||
| A. M. Levine | |||
| M. Mizokami | |||
| B. N. Nathwani | |||
| E. Zuckerman | |||
| D. G. Qian | |||
| K. Gutekunst | |||
| M. Velankar | |||
| T. Zuckerman | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis C virus | Q708693 |
| hepatitis C | Q154869 | ||
| P304 | page(s) | 423-428 | |
| P577 | publication date | 1997-09-01 | |
| 1997-09-15 | |||
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma | |
| Hepatitis C Virus Infection in Patients with B-Cell Non-Hodgkin Lymphoma | |||
| P478 | volume | 127 |
| Q40288450 | A Role for RNA Viruses in the Pathogenesis of Burkitt's Lymphoma: The Need for Reappraisal |
| Q51011838 | A collaborative nationwide lymphoma study in Lebanon: incidence of various subtypes and analysis of associations with viruses |
| Q35085734 | A search for overlapping genetic susceptibility loci between non-Hodgkin lymphoma and autoimmune diseases |
| Q57208129 | Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients |
| Q84069714 | Adult post-transplant lymphoproliferative disease in the liver graft in patients with recurrent hepatitis C |
| Q27480341 | Analysis of Hepatitis C Virus Hypervariable Region 1 Sequence from Cryoglobulinemic Patients and Associated Controls |
| Q34545880 | Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules. |
| Q57661008 | Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C |
| Q40584442 | Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma. |
| Q38270640 | Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study |
| Q36524424 | Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection |
| Q42980242 | Anti‐HCV and HCV‐RNA prevalence and clinical correlations in cases with non‐Hodgkin's lymphoma |
| Q43037261 | Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection |
| Q45749351 | Association between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course |
| Q36607038 | B cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes |
| Q43040346 | B-cell lymphomas involving the skin associated with hepatitis C virus infection. |
| Q35797604 | B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review |
| Q46231465 | Case of chronic eosinophilic leukemia with deletion of chromosome 16 and hepatitis C. |
| Q73414223 | Cells of the marginal zone--origins, function and neoplasia |
| Q43033654 | Characteristics and outcome of B-cell chronic lymphocytic leukemia in hepatitis C virus-positive patients |
| Q33378075 | Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients |
| Q42210964 | Clinical outcome of HCV-positive patients with diffuse large B-cell lymphoma treated with rituximab-based chemotherapy |
| Q37325965 | Common immune-related risk factors and incident non-Hodgkin lymphoma: the multiethnic cohort |
| Q27470018 | Compartmentalization of hepatitis C virus quasispecies in blood mononuclear cells of patients with mixed cryoglobulinemic syndrome |
| Q45394454 | Concomitant diffuse large B-cell lymphoma and hepatocellular carcinoma in chronic hepatitis C virus liver disease: a study of two cases |
| Q29620057 | Course and outcome of hepatitis C |
| Q33811619 | Cryoglobulinemia |
| Q33806419 | Cryoglobulinemic vasculitis |
| Q24673191 | Cryoglobulins |
| Q42986001 | Detection of hepatitis C virus RNA in paraffin-embedded tissues from patients with non-Hodgkin's lymphoma |
| Q61873087 | Detection of occult low-grade B-cell non-hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia |
| Q42988958 | Does the hepatitis C virus replicate in cells of the hematopoietic lineage? |
| Q51626523 | Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era. |
| Q35911859 | Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies |
| Q38676280 | Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma. |
| Q37280928 | Epidemiology, pathology and treatment of non-follicular indolent lymphomas |
| Q27473088 | Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection |
| Q73315124 | Expansion of CD5+ B-cell overexpressing CD81 in HCV infection: towards better understanding the link between HCV infection, B-cell activation and lymphoproliferation |
| Q33715911 | Extrahepatic manifestations of HCV infection: facts and controversies |
| Q45746740 | Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. |
| Q45333951 | Extrahepatic manifestations of hepatitis C among United States male veterans |
| Q36410569 | Extrahepatic manifestations of hepatitis C virus |
| Q36519154 | Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences |
| Q38470211 | Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France |
| Q45729966 | Focal liver lesions in non-Hodgkin's lymphoma: investigation of their prevalence, clinical significance and the role of Hepatitis C virus infection |
| Q35119527 | HCV Infection and B-Cell Lymphomagenesis |
| Q36971042 | HCV-related autoimmune and neoplastic disorders: the HCV syndrome |
| Q37780706 | HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma |
| Q57648077 | Hepatic B-cell non-Hodgkin's lymphoma of MALT type in the liver explant of a patient with chronic hepatitis C infection |
| Q44010172 | Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study |
| Q26781743 | Hepatitis C Associated B-cell Non-Hodgkin Lymphoma: Clinical Features and the Role of Antiviral Therapy |
| Q27486411 | Hepatitis C Virus (HCV)-Induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope Protein |
| Q37961614 | Hepatitis C and Non-Hodgkin Lymphoma: The Clinical Perspective |
| Q78772221 | Hepatitis C infection and B-cell non-Hodgkin's lymphoma |
| Q73047947 | Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: a cross-sectional analysis |
| Q34552105 | Hepatitis C infection and lymphoproliferative disease: accidental comorbidities? |
| Q73189352 | Hepatitis C infection in lymphoma patients in a Turkish center |
| Q40216845 | Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study. |
| Q35198912 | Hepatitis C virus (HCV) and lymphomagenesis |
| Q36826365 | Hepatitis C virus (HCV)-related cryoglobulinemia: cryoglobulin type and anti-HCV profile |
| Q43048170 | Hepatitis C virus and GBV-C virus prevalence among patients with B-cell lymphoma in different European regions: a case-control study of the International Extranodal Lymphoma Study Group. |
| Q38244519 | Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment |
| Q44688321 | Hepatitis C virus and malignancy |
| Q26775007 | Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options |
| Q92132449 | Hepatitis C virus and risk of extrahepatic malignancies: a case-control study |
| Q36244165 | Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7.2. |
| Q42982075 | Hepatitis C virus in patients with non-Hodgkin's lymphoma in southeastern Anatolia region of Turkey: a prospective case-control study of 119 patients |
| Q41877364 | Hepatitis C virus infection among patients with non-Hodgkin’s lymphoma in northern India |
| Q38057221 | Hepatitis C virus infection and autoimmune diseases |
| Q42991127 | Hepatitis C virus infection and cryoglobulinemia |
| Q95779220 | Hepatitis C virus infection and lymphoma |
| Q45742402 | Hepatitis C virus infection and lymphoproliferative diseases in France: a national study. The GERMIVIC Group |
| Q45737062 | Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France |
| Q42997806 | Hepatitis C virus infection and lymphoproliferative disorders after liver transplantation |
| Q42985499 | Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study |
| Q43048174 | Hepatitis C virus infection in Lebanese patients with B-cell non-Hodgkin's lymphoma |
| Q43040334 | Hepatitis C virus infection in patients with B-cell lymphoproliferative disorders |
| Q42995896 | Hepatitis C virus infection, Sjögren's syndrome, and non-Hodgkin's lymphoma |
| Q42991870 | Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: an emerging picture |
| Q43648279 | Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection |
| Q43001508 | Hepatitis C virus related lymphoproliferative disorder in a renal transplant recipient |
| Q35237312 | Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer |
| Q36081089 | Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations |
| Q36292860 | Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma. |
| Q43038855 | Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS. |
| Q33363781 | Hepatitis C virus-associated extrahepatic manifestations: a review |
| Q37371397 | Hepatitis C virus-induced cryoglobulinemia |
| Q34098553 | Hepatitis C virus-related lymphoproliferative disorders: an overview. |
| Q33366747 | Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura |
| Q45704529 | Hepatitis C virus: simply too smart to be just a liver pathogen |
| Q42989683 | Hepatitis C-related posttransplant plasma cell proliferative disorder with hepatitis C virus in neoplastic plasma cells: a new posttransplant disease entity? |
| Q34107873 | Hepatitis c and lymphoma |
| Q45889715 | Hepatitis in haemophilia |
| Q34228753 | Hepatitis-C Infection Incidence Among the non-Hodgkin's B-cell Lymphoma Patients in the Northeast of Iran. |
| Q45395665 | High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea |
| Q37489982 | High prevalence of viral hepatitis in a series of splenic marginal zone lymphomas from Romania. |
| Q27491280 | Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders |
| Q27478232 | Immunoglobulin Gene Mutations and Frequent Use of VH1-69 and VH4-34 Segments in Hepatitis C Virus-Positive and Hepatitis C Virus-Negative Nodal Marginal Zone B-Cell Lymphoma |
| Q102369356 | Impact of deranged B cell subsets distribution in the development of HCV-related cirrhosis and HCC in type two diabetes mellitus |
| Q45403597 | Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection |
| Q37734105 | Increased frequency of micronuclei in the lymphocytes of patients chronically infected with hepatitis B or hepatitis C virus |
| Q40981955 | Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010. |
| Q57218931 | LACK OF ASSOCIATION BETWEEN HCV INFECTION AND HIV-RELATED LYMPHOMA |
| Q35782582 | Leukaemic subtype of marginal zone lymphoma: a presentation of three cases and literature review. |
| Q45753804 | Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies |
| Q43042179 | Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection |
| Q34162187 | Lymphoid malignancies: the dark side of B-cell differentiation |
| Q33427078 | Lymphoma Remission by Interferon-Free HCV Eradication Without Chemotherapy |
| Q34402277 | Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells |
| Q33588847 | Lymphomas in patients with Sjögren's syndrome: review of the literature and physiopathologic hypothesis |
| Q74475105 | Malignant liver tumors |
| Q38947451 | Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5). |
| Q34600740 | Marginal zone cell lymphoma--an update on recent advances |
| Q36971072 | Mixed cryoglobulinemia: a model of virus-related disease in internal medicine |
| Q42993576 | Multicenter study on hepatitis C virus infection in patients with dilated cardiomyopathy. North Italy Transplant Program (NITP). |
| Q34427560 | Multiparametric analyses of human PBMCs loaded ex vivo with a candidate idiotype vaccine for HCV-related lymphoproliferative disorders |
| Q42992786 | No association between hepatitis C and B-cell lymphoma |
| Q43047776 | No association between lymphoma and hepatitis C virus |
| Q36619692 | No evidence of hepatitis C virus infection in Serbian patients with oral leukoplakia |
| Q36322056 | Nodal and splenic marginal zone B cell lymphomas |
| Q38134139 | Nodal marginal zone lymphoma |
| Q37528530 | Nodal marginal zone lymphoma: current knowledge and future directions of an heterogeneous disease. |
| Q34314762 | Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy |
| Q45509091 | Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection |
| Q37061544 | Oral diseases associated with hepatitis C virus infection. Part 1. sialadenitis and salivary glands lymphoma |
| Q35134887 | Oral diseases possibly associated with hepatitis C virus |
| Q42998818 | PCR testing for HCV in anti-HCV negative blood donors involved in the so called HCV +ve post-transfusion hepatitis |
| Q41461550 | Paediatric nodal marginal zone B-cell lymphadenopathy of the neck: a Haemophilus influenzae-driven immune disorder? |
| Q30425213 | Pandemic (H1N1) 2009 Influenza in Pediatric Hematology/Oncology Units in Lebanon |
| Q35208308 | Peripheral B Cells as Reservoirs for Persistent HCV Infection |
| Q27480668 | Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection |
| Q51035966 | Peripheral blood memory B cells are resistant to apoptosis in chronic hepatitis C patients |
| Q35868937 | Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review. |
| Q41894042 | Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach |
| Q42983243 | Presence of hepatitis C virus DNA sequences in the DNA of infected patients |
| Q34621540 | Prevalence of hepatitis C virus and hepatitis G virus in patients with non-Hodgkin's lymphoma |
| Q42236858 | Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey |
| Q42999139 | Prevalence of hepatitis-G virus and hepatitis-C virus infection in patients with non-Hodgkin's lymphoma |
| Q64046933 | Primary liver lymphoma in a patient with chronic hepatitis C |
| Q46650974 | Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia |
| Q26996650 | Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review |
| Q45382252 | Regression of B-cell lymphoma of the liver with hepatitis C virus infection after treatment with pegylated interferon-alpha and ribavirin |
| Q42986628 | Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas |
| Q28393906 | Risk of lymphatic or haematopoietic cancer mortality with occupational exposure to animals or the public |
| Q36167378 | Rituximab-based treatment, HCV replication, and hepatic flares |
| Q44632723 | Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation |
| Q43980765 | Sarcoidosis-associated hepatitis C virus infection |
| Q43033850 | Simultaneous hepatic relapse of non-Hodgkin's lymphoma and hepatocellular carcinoma in a patient with hepatitis C virus-related cirrhosis |
| Q42982069 | Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles |
| Q50574927 | Splenic lymphoma with villous lymphocytes revealed by purpura pigmentosa progressiva associated with cryoglobulinemia and chronic hepatitis C infection |
| Q36971055 | Splenic lymphoma with villous lymphocytes, mixed cryoglobulinemia and HCV infection: deciphering the role of HCV in B-cell lymphomagenesis |
| Q48331134 | Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era. |
| Q34075757 | Strategies to reduce the risk of virus-related cancers. |
| Q43000081 | Sustained response to interferon-alpha2a monotherapy of young blood donors with minimal-to-mild chronic hepatitis C. The Donor Surveillance Study Group |
| Q31154023 | Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection. |
| Q75195691 | Systematic screening for HCV infection should be performed in patients with splenic marginal zone lymphoma |
| Q45744785 | T(14;18) translocation in chronic hepatitis C virus infection |
| Q37115530 | T-cell non-Hodgkin's lymphoma presenting after clearance of hepatitis C: a case report and review of the literature |
| Q51626445 | The bendamustine plus rituximab regimen is active against primary nodal marginal zone B-cell lymphoma |
| Q34308860 | The cryoglobulins: an overview |
| Q34601452 | The epidemiology and pathogenesis of neoplasia in the small intestine |
| Q38052844 | The hepatitis C virus infection as a systemic disease |
| Q35122636 | The hepatitis C virus persistence: how to evade the immune system? |
| Q42989114 | The prevalence of hepatitis C and hepatitis G virus infection in patients with B cell non-Hodgkin lymphomas in Greece: a Hellenic Cooperative Oncology Group Study |
| Q44254387 | The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis |
| Q33364746 | Treatment of immune thrombocytopenia associated with interferon therapy of hepatitis C with the anti-CD20 monoclonal antibody, rituximab |
| Q36645733 | Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypes. |
| Q34170425 | Viral hepatitis A, B, and C. |
| Q38106958 | Virus-associated lymphomagenesis |
| Q38298448 | Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection. |
| Q73829788 | [Non-Hodgkin's lymphoma and hepatitis C virus] |
| Q45738841 | bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection |
Search more.